相关实验视频
Updated: Jun 21, 2025
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.2K
炎症性肠病:对分子基础,预测生物标志物,诊断方法和治疗选择的全面分析
Eguzkiñe Diez-Martin1,2, Leidi Hernandez-Suarez1,2, Carmen Muñoz-Villafranca3
1Research and Development Department, IMG Pharma Biotech S.L., 48170 Zamudio, Spain.
International journal of molecular sciences
|July 13, 2024
概括
炎症性肠道疾病 (IBD) 涉及对肠道的免疫攻击. 了解分子因素,生物标志物和抗TNF疗法等治疗方法是治疗克罗恩病和性结肠炎的关键.
科学领域:
- 胃肠道学和免疫学
- 分子生物学分子生物学
- 微生物组学 微生物组学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),是慢性疾病,其特征是免疫系统介导的肠损伤.
- 复杂的IBD病因涉及到破坏分子通路的遗传,环境,微生物群和免疫学因素.
- 肠道微生物群和免疫细胞相互作用,与微生物抗原和自身抗体相互作用,导致炎症和组织损伤.
研究的目的:
- 审查IBD的分子基础和目标.
- 讨论IBD的诊断和预后生物标志物.
- 探索IBD目前和新兴的治疗策略和监测技术.
主要方法:
- 文献综述侧重于分子机制,生物标志物和IBD治疗干预措施.
- 在IBD病变发生过程中,微生物群,免疫细胞和自身抗体之间的相互作用的分析.
- 检查诊断标记物 (例如,C反应蛋白,便calprotectin) 和治疗点 (例如,TNF,整体素).
主要成果:
- IBD的发病是由遗传倾向,环境触发因素,肠道微生物群失调和异常免疫反应的复杂相互作用驱动的.
- 分子生物标志物对于准确的IBD诊断,预后和IBD活动监测至关重要.
- 针对瘤死因 (TNF) 和整合素等炎症分子的生物药物代表了IBD治疗的重大进展.
结论:
- 对IBD分子基础的全面理解对于有效的患者管理至关重要.
- 基于分子分析和生物标志物分析的个性化治疗策略有望改善IBD的结果.
- 解决IBD管理方面的挑战需要对新的治疗目标和监测方法进行持续的研究.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
01:29Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
01:30Inflammatory Bowel Disease II: Crohn's Disease
212
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
212
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:21Inflammatory Bowel Disease V: Surgical Management
139
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
139